Digital cognitive behavioral therapy for depression
Official title: Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study
Run by Peking University · NCT06831435 · Data updated 2026-11-12
This project will test a self-developed mobile app that delivers eight weeks of AI-guided digital CBT with weekly lessons and homework for people aged 14–60 who have depression.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years to 60 Years |
| Sex | All |
| Enrollment | 325 (estimated) |
| Sponsor | Peking University Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | November 13, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | December 15, 2025 |
| Trial ID | NCT06831435 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 14–60 with a HAMD score of 14 or higher who can provide informed consent (or whose guardian can consent if they are minors) and can attend visits at the study site.
✕Probably not a fit
People with severe suicidal tendencies or who require immediate inpatient psychiatric care are unlikely to benefit from this outpatient digital CBT program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will deliver an 8-week cognitive behavioral therapy program through a self-developed mobile applet, with weekly sessions that include AI-guided coursework and homework created by psychotherapists. The project is set up as a real-world interventional study enrolling patients with HAMD scores ≥14 and excludes those with severe suicidal tendencies per MADRS item 10. In addition to symptom outcomes, the protocol includes exploration of genetic and neuroimaging correlates to understand biological mechanisms. All clinical visits and assessments are conducted at Peking University Sixth Hospital in Beijing.
Why it matters
Potential benefit: If successful, this app could reduce depressive symptoms and increase access to therapist-informed CBT through a scalable, home-based program.
How similar studies have gone: Digital CBT has demonstrated benefit for mild-to-moderate depression in multiple prior trials, but AI-guided applets and the added genetic/neuroimaging components are less established in real-world settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 14-60 years (including 14 and 60), no gender restriction; 2. HAMD \>= 14; 3. Written informed consent obtained from the patient; written informed consent obtained from the guardian for minors. Exclusion Criteria: * Persons with severe suicidal tendencies (item 10 of the MADRS scale ≥ 5).
Where it's running
-
Peking University Sixth Hostipal
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Weihua Yue
- Email: dryue@bjmu.edu.cn
- Phone: 86-010-82805307
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
Remote monitoring for adults with depression using ThIA Suivi
This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.
-
Quality of life and safety in quetiapine use for schizophrenia or bipolar disorder
This study looks at how patients with schizophrenia or bipolar disorder feel and stay safe when treated with quetiapine alone or with other antipsychotics.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.